RxDoctor Payments Data

Richard Gunning, MD

Family Medicine · Norton, OHNPI 1508856915

Payments from drug & device makers

$11,846in general payments, 2019–2025

Across 749 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Novo Nordisk$890
  • Amgen$690
  • Pfizer$678
  • plus $6K from 44 others

What the payments were for

  • Food & beverage$11,835100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,846 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$73,061
Medicare patients
173
Services billed
854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban105$101,184
JardianceEmpagliflozin31$38,032
XareltoRivaroxaban28$29,025
TrulicityDulaglutide22$28,953
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$21,637
FarxigaDapagliflozin Propanediol13$16,990
JanuviaSitagliptin Phosphate18$16,702
Tresiba Flextouch U-100Insulin Degludec12$10,482
TradjentaLinagliptin12$9,159
Breo ElliptaFluticasone/Vilanterol12$4,801
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$4,475
Levothyroxine Sodium298$3,637
Albuterol Sulfate HfaAlbuterol Sulfate92$3,302
Metoprolol Succinate197$2,434
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$1,972

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$678$101,184105 claims
Boehringer IngelheimJardiance, Tradjenta$508$47,19143 claims
Johnson & JohnsonXarelto$169$29,02528 claims
Lilly USA, LLCTrulicity$1,338$28,95322 claims
GSKTrelegy Ellipta, Breo Ellipta$591$26,43839 claims
AstraZenecaFarxiga$1,306$16,99013 claims
MerckJanuvia$191$16,70218 claims
AbbVieSynthroid$1,380$1,00719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Norton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →